| Product Code: ETC9625956 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Taiwan Oncology Market Overview |
3.1 Taiwan Country Macro Economic Indicators |
3.2 Taiwan Oncology Market Revenues & Volume, 2021 & 2031F |
3.3 Taiwan Oncology Market - Industry Life Cycle |
3.4 Taiwan Oncology Market - Porter's Five Forces |
3.5 Taiwan Oncology Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.6 Taiwan Oncology Market Revenues & Volume Share, By End-use, 2021 & 2031F |
4 Taiwan Oncology Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Taiwan |
4.2.2 Growing adoption of advanced oncology treatments and technologies |
4.2.3 Government initiatives to improve cancer care and access to oncology services |
4.3 Market Restraints |
4.3.1 High treatment costs associated with oncology therapies |
4.3.2 Limited access to specialized oncologists in certain regions of Taiwan |
4.3.3 Stringent regulatory requirements for approval of new oncology drugs |
5 Taiwan Oncology Market Trends |
6 Taiwan Oncology Market, By Types |
6.1 Taiwan Oncology Market, By Cancer Type |
6.1.1 Overview and Analysis |
6.1.2 Taiwan Oncology Market Revenues & Volume, By Cancer Type, 2021- 2031F |
6.1.3 Taiwan Oncology Market Revenues & Volume, By Lung cancer, 2021- 2031F |
6.1.4 Taiwan Oncology Market Revenues & Volume, By Prostate cancer, 2021- 2031F |
6.1.5 Taiwan Oncology Market Revenues & Volume, By Colon & rectal cancer, 2021- 2031F |
6.1.6 Taiwan Oncology Market Revenues & Volume, By Gastric cancer, 2021- 2031F |
6.1.7 Taiwan Oncology Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Taiwan Oncology Market, By End-use |
6.2.1 Overview and Analysis |
6.2.2 Taiwan Oncology Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.2.3 Taiwan Oncology Market Revenues & Volume, By Diagnostic laboratories, 2021- 2031F |
6.2.4 Taiwan Oncology Market Revenues & Volume, By Diagnostic imaging centers, 2021- 2031F |
6.2.5 Taiwan Oncology Market Revenues & Volume, By Academia, 2021- 2031F |
6.2.6 Taiwan Oncology Market Revenues & Volume, By Specialty clinics, 2021- 2031F |
6.2.7 Taiwan Oncology Market Revenues & Volume, By Others, 2021- 2031F |
7 Taiwan Oncology Market Import-Export Trade Statistics |
7.1 Taiwan Oncology Market Export to Major Countries |
7.2 Taiwan Oncology Market Imports from Major Countries |
8 Taiwan Oncology Market Key Performance Indicators |
8.1 Patient survival rates post-treatment |
8.2 Number of clinical trials conducted for oncology treatments in Taiwan |
8.3 Adoption rate of precision medicine approaches in oncology treatment |
8.4 Percentage of oncology patients receiving timely diagnosis and treatment |
8.5 Rate of utilization of palliative care services in oncology patients |
9 Taiwan Oncology Market - Opportunity Assessment |
9.1 Taiwan Oncology Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
9.2 Taiwan Oncology Market Opportunity Assessment, By End-use, 2021 & 2031F |
10 Taiwan Oncology Market - Competitive Landscape |
10.1 Taiwan Oncology Market Revenue Share, By Companies, 2024 |
10.2 Taiwan Oncology Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here